LIVE UPDATES: FDA ‘rapidly working’ to finalize Pfizer coronavirus vaccine approval


A U.S. Food and Drug Administration advisory panel voted Thursday to endorse the Pfizer-BioNTech coronavirus vaccine, clearing the way for FDA leaders to authorize emergency mass distribution amid an ongoing surge of COVID-19 cases across the country.

In a joint statement released after the vote, FDA Commissioner Dr. Stephen Hahn and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said the agency will now “rapidly work toward finalization and issuance of an emergency use authorization.” 

Fast Facts

    • The recommendation clears the way for FDA leaders to authorize emergency mass distribution 
    • Vaccine shipments would begin within hours of the FDA’s decision, which could come by as early as Friday
    • Pfizer’s vaccine will be available in limited quantities, with initial doses earmarked for frontline health care workers and high-risk patients.

Vaccine shipments would begin within hours of the FDA’s decision, which could come by as early as Friday, with the first vaccinations to follow soon afterward. Pfizer’s vaccine will be available in limited quantities, with initial doses earmarked for frontline health care workers and high-risk patients.

In November, Pfizer announced that its coronavirus vaccine was 95 percent effective and has not displayed any major side effects.

Follow below for updates on the coronavirus pandemic. Mobile users click here.



Source link